Ziółkowski, Piotr
Woźniak, Marta
Mansour, Ahmad
An, Yu
Weber, Georg F.
Funding for this research was provided by:
National Cancer Institute (CA224104)
Marlene Harris-Ride Cincinnati (pilot grant)
Article History
Received: 22 April 2022
Accepted: 23 September 2022
First Online: 29 September 2022
Declarations
:
: The study was approved by the Local Ethics Committee at Wroclaw Medical University, Poland, in 2016 (no. 41/16). No consent from patients was needed. It was covered by University of Cincinnati/IRB Protocol 2021-0043 Osteopontin splice variants in premalignant breast lesions.
: The authors declare no competing interests.